Cancer Type: Sarcoma

For more information about any of the clinical trials listed on this site, call 314-747-7222 or 800-600-3606 toll free or email Patient_Care_[email protected].

Select Basic Search to view clinical trials grouped by category and Advanced Search to be able to further narrow search results.

 

Switch to Advanced Search

202012066

Brief Summary Part 1 is the dose escalation of APG-115 in combination with label dose of pembrolizumab.

202101200

Brief Summary Part 1: Dose Escalation. The primary objective of Part 1 of this study is to evaluate the safety and tolerability of KB-0742 in participants with relapsed or refractory (R/R) solid tumors or non-Hodgkin lymphoma (NHL).

202103209

202105158

202105163

202106131

202107082

202107168

202108161

202112016